This is the world’s first application for the approval of a regenerative medical treatment product made from iPS cells. The health care company Cuorips, whose research is led by Dr. Yoshiki Sawa ...

This file photo taken at the University of Osaka in Suita, Osaka Prefecture, in January 2024, shows a cardiac muscle sheet made from iPS cells. (Kyodo) OSAKA (Kyodo) -- A startup in Tokyo on ...

A venture firm in Japan says it has applied to the health ministry for approval to produce and sell sheets of heart muscle cells derived from induced pluripotent stem cells, or iPS cells, to be ...

There’s unexpected movement in the world of cell biology — specifically, with the energy factories known as mitochondria. Ever since they were discovered in the mid-nineteenth century ...

School of Chemical Engineering and State Key Laboratory of Polymer Materials Engineering, Sichuan University, Chengdu 610065, P. R. China ...

Conventional stem cells retain the age of the donor — a 50-year-old person's stem cells still retain the characteristics of 50 years old. In contrast, iPS cells enable the extraction of youthful ...

More information: Toshikazu Araoka et al, Human iPSC–derived nephron progenitor cells treat acute kidney injury and chronic kidney disease in mouse models, Science Translational Medicine (2025).

We recently showed that NPCs derived from human induced pluripotent stem cells (iPSCs) represent an effective model system for mtDNA disease drug discovery (Lorenz et al, Cell Stem Cell 2017). Here, ...

Three iMSC lines, derived from iPSC differentiation experiments (SD1, SD2 and SD3) were expanded in XFS-containing medium from P8 to P19 in a continuous long-term culture (∼100 days). Cell morphology ...

The stem cell treatment involved the injection of roughly two million reprogrammed or induced pluripotent stem (iPS) cells, which are created by hacking adult cells back into an embryonic-like state.